DexCom, Inc. (DXCM)
91.04
-1.30
(-1.41%)
USD |
NASDAQ |
Aug 24, 16:00
91.52
+0.48
(+0.53%)
After-Hours: 20:00
DexCom Shareholders Equity (Quarterly) : 2.621B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.621B |
| March 31, 2026 | 2.957B |
| December 31, 2025 | 2.746B |
| September 30, 2025 | 2.726B |
| June 30, 2025 | 2.573B |
| March 31, 2025 | 2.267B |
| December 31, 2024 | 2.103B |
| September 30, 2024 | 1.979B |
| June 30, 2024 | 2.434B |
| March 31, 2024 | 2.247B |
| December 31, 2023 | 2.069B |
| September 30, 2023 | 2.268B |
| June 30, 2023 | 2.100B |
| March 31, 2023 | 2.233B |
| December 31, 2022 | 2.132B |
| September 30, 2022 | 1.824B |
| June 30, 2022 | 2.256B |
| March 31, 2022 | 2.189B |
| December 31, 2021 | 2.042B |
| September 30, 2021 | 2.136B |
| June 30, 2021 | 1.998B |
| March 31, 2021 | 1.903B |
| December 31, 2020 | 1.826B |
| September 30, 2020 | 1.499B |
| June 30, 2020 | 1.354B |
| Date | Value |
|---|---|
| March 31, 2020 | 934.50M |
| December 31, 2019 | 882.60M |
| September 30, 2019 | 764.30M |
| June 30, 2019 | 688.30M |
| March 31, 2019 | 668.60M |
| December 31, 2018 | 663.30M |
| September 30, 2018 | 562.20M |
| June 30, 2018 | 482.10M |
| March 31, 2018 | 421.70M |
| December 31, 2017 | 419.40M |
| September 30, 2017 | 384.00M |
| June 30, 2017 | 353.70M |
| March 31, 2017 | 277.80M |
| December 31, 2016 | 283.80M |
| September 30, 2016 | 261.80M |
| June 30, 2016 | 246.40M |
| March 31, 2016 | 231.20M |
| December 31, 2015 | 221.20M |
| September 30, 2015 | 193.30M |
| June 30, 2015 | 170.70M |
| March 31, 2015 | 148.60M |
| December 31, 2014 | 140.20M |
| September 30, 2014 | 115.00M |
| June 30, 2014 | 99.60M |
| March 31, 2014 | 90.00M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Abbott Laboratories | 51.11B |
| Insulet Corp. | 1.422B |
| Baxter International, Inc. | 6.206B |
| Globus Medical, Inc. | 4.769B |
| Stryker Corp. | 23.99B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.455B |
| Total Liabilities (Quarterly) | 3.834B |
| Debt to Equity Ratio | 0.5335 |
| Current Ratio | 1.733 |
| Net Debt Paydown Yield | 0.93% |